Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study

Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed.

Gespeichert in:
Autor*in:

Petitdidier, Nicolas [verfasserIn]

Tannoury, Jenny

de’Angelis, Nicola

Gagniere, Charlotte

Hulin, Anne

Rotkopf, Hugo

Mesli, Farida

Brunetti, Francesco

Sobhani, Iradj

Amiot, Aurelien

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2019

Schlagwörter:

Inflammatory bowel disease

Infliximab

CT-P13

Biosimilar

Crohn’s disease

Ulcerative colitis

Umfang:

9

Übergeordnetes Werk:

Enthalten in: The relationship between physical performance and cardiac function in an elderly Russian cohort - Tadjibaev, Pulod ELSEVIER, 2014, official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, [S.l.]

Übergeordnetes Werk:

volume:51 ; year:2019 ; number:12 ; pages:1652-1660 ; extent:9

Links:

Volltext

DOI / URN:

10.1016/j.dld.2019.08.020

Katalog-ID:

ELV048583448

Nicht das Richtige dabei?

Schreiben Sie uns!